High Levels of Endogenous Estrogens are Associated With Death in the Critically Injured Adult
- 1 March 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma: Injury, Infection & Critical Care
- Vol. 64 (3) , 580-585
Abstract
Background: Sex hormones exhibit predictable changes in their physiologic patterns during critical illness. Endogenous estrogens are elevated in both genders as a result of the peripheral conversion of androgens to estrogens by the aromatase enzyme. Elevated endogenous estrogens have been associated with death in medical and mixed surgical intensive care unit (ICU) patients. Our objective was to determine the relationship between endogenous estrogens and outcomes in critically injured patients. Methods: A prospective cohort of injured patients remaining in the ICU for at least 48 hours at two trauma centers was enrolled. Sex hormones (estradiol, progesterone, testosterone, prolactin, and dehydroepiandrosterone-sulfate) were assayed and mortality was assessed. A logistic regression model was used to determine the association between estradiol and death. The area under the receiver operating characteristic (AUROC) curve was used to estimate the accuracy of estradiol in predicting death. Results: Nine hundred ninety-one patients were enrolled with a 13.4% mortality rate. Despite no detectable difference in mortality among genders, estradiol was significantly elevated in nonsurvivors (16 pg/mL vs. 35 pg/mL, p < 0.001). Estradiol was a marker for injury severity with the most severely injured patients exhibiting the highest levels. The ability of estradiol to predict death (AUROC = 0.65) was comparable with Trauma and Injury Severity Score (AUROC = 0.65) and superior to Injury Severity Score (AUROC = 0.54) in this cohort. Conclusions: Serum estradiol is a marker of injury severity and a predictor of death in the critically injured patient, regardless of gender. Whether or not estradiol plays a causal role in outcomes is unclear, but estrogen modulation represents a potential therapy for improving outcomes in critically ill trauma patients.Keywords
This publication has 39 references indexed in Scilit:
- Estradiol is associated with mortality in critically ill trauma and surgical patientsCritical Care Medicine, 2008
- Gender-Specific Differences in Sex Hormones and Cytokines in Patients Undergoing Major Abdominal SurgerySurgery Today, 2005
- Gender-related differences in intensive care: A multiple-center cohort study of therapeutic interventions and outcome in critically ill patients*Critical Care Medicine, 2003
- The Association between Gender and Mortality among Trauma Patients as Modified by Age2003
- Does Gender Difference Influence Outcome?2002
- Gender Differences in Adverse Outcomes after Blunt TraumaThe Journal of Trauma: Injury, Infection, and Critical Care, 2001
- THE AROMATASE INHIBITOR, 4-HYDROXYANDROSTENEDIONE, RESTORES IMMUNE RESPONSES FOLLOWING TRAUMA-HEMORRHAGE IN MALES AND DECREASES MORTALITY FROM SUBSEQUENT SEPSISShock, 2000
- Females in proestrus state maintain splenic immune functions and tolerate sepsis better than malesCritical Care Medicine, 1997
- Effect of the aromatase inhibitor, 4 hydroxyandrostenedione, on the endotoxin-induced changes in steroid hormones in male ratsLife Sciences, 1992
- Sex steroids, glucocorticoids, stress and autoimmunityThe Journal of Steroid Biochemistry and Molecular Biology, 1991